Victor Villegas is an Ophthalmology physician. OpenAlex indexes 107 publications with 1,067 citations (h-index 16).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
360 Calle Del Parque
Ciudadela Suite 1
San Juan, PR 009210001
Telephone
787-919-3156Registry record last updated 15 Jun 2018.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202512 payments
- Samsara VisionProgram year20251 payment
- Bausch & Lomb Americas Inc.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
82.2%Prostaglandin Analog24.3%Latanoprost76%Lumigan22%Travoprost2%Bimatoprost1%Part D<11 patientsCorticosteroid20.7%Fluorometholone55%Prednisolone Acetate45%Part D≥228 patients+ 9 more classes in this area
Musculoskeletal
12.7%Cyclooxygenase Inhibitor12.7%Ketorolac Tromethamine100%Part D≥174 patientsAnti-infectives
1.7%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.6%Valacyclovir100%Part D≥14 patientsMacrolide0.6%Erythromycin100%Part D≥18 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Retinoblastoma Outcomes in the Americas: A Prospective Analysis of 491 Children With Retinoblastoma From 23 American Countries
American Journal of Ophthalmology
2023 - Update on current pharmacologic therapies for diabetic retinopathy
Expert Opinion on Pharmacotherapy
2023 - Bilateral vitreomacular traction syndrome associated with topical pilocarpine 1% ophthalmic solution
American Journal of Ophthalmology Case Reports
2023
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”